España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
ADC Therapeutics
ADCT
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.68
-0.04
-2.33%
At close: -
$1.67
-0.01
-0.60%
After Hours: Jan 31, 4:16 PM EDT
Get Report
Comment
ADC Therapeutics (ADCT) Forecast
News
Earnings
ADC Therapeutics (ADCT) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for ADC Therapeutics (NYSE:ADCT) Stock
ADC Therapeutics Stock (NYSE: ADCT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, January 06, 2025
HC Wainwright & Co. Reiterates Buy on ADC The...
Benzinga Newsdesk
Monday, December 30, 2024
ADC Therapeutics Completes Enrollment In LOTI...
Benzinga Newsdesk
Thursday, December 12, 2024
Guggenheim Reiterates Buy on ADC Therapeutics...
Benzinga Newsdesk
Wednesday, December 11, 2024
HC Wainwright & Co. Reiterates Buy on ADC The...
Benzinga Newsdesk
ADC Therapeutics shares are trading higher af...
Benzinga Newsdesk
ADC Therapeutics Announced Positive Initial D...
Benzinga Newsdesk
Friday, December 06, 2024
ADC Therapeutics shares are trading higher af...
Benzinga Newsdesk
ADC Therapeutics Says It Will Provide Initial...
Benzinga Newsdesk
Friday, November 08, 2024
ADC Therapeutics Faces Competitive Oncology Market But Analyst Sees 100% Upside - Here's Why
Vandana Singh
Stephens & Co. Initiates Coverage On ADC Ther...
Benzinga Newsdesk
Thursday, November 07, 2024
ADC Therapeutics Q3 2024 Adj. EPS $(0.28) Bea...
Benzinga Newsdesk
Wednesday, November 06, 2024
ADC Therapeutics's Earnings: A Preview
Benzinga Insights
Thursday, August 08, 2024
HC Wainwright & Co. Reiterates Buy on ADC The...
Benzinga Newsdesk
Wednesday, August 07, 2024
RBC Capital Reiterates Outperform on ADC Ther...
Benzinga Newsdesk
Tuesday, August 06, 2024
ADC Therapeutics' Cash And Cash Equivalents W...
Benzinga Newsdesk
ADC Therapeutics Q2 2024 Adj. EPS $(0.25) Bea...
Benzinga Newsdesk
Monday, July 08, 2024
Intapp, ServiceNow And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
Thursday, June 27, 2024
ADC Therapeutics Is Set To Join The Russell 2...
Benzinga Newsdesk
Thursday, May 30, 2024
Cantor Fitzgerald Initiates Coverage On ADC T...
Benzinga Newsdesk
Tuesday, May 07, 2024
HC Wainwright & Co. Maintains Buy on ADC Ther...
Benzinga Newsdesk
Monday, May 06, 2024
BioNTech Reports Downbeat Earnings, Joins Medical Properties Trust And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
ADC Therapeutics Currently Expects Its Cash R...
Benzinga Newsdesk
ADC Therapeutics Q1 2024 Adj EPS $(0.38) Beat...
Benzinga Newsdesk
ADC Therapeutics Announces Initial Data from ...
Benzinga Newsdesk
Tuesday, April 30, 2024
Medifast Reports Mixed Results, Joins Coursera, Chegg And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Avi Kapoor
Monday, April 15, 2024
HC Wainwright & Co. Reiterates Buy on ADC The...
Benzinga Newsdesk
Friday, April 05, 2024
Guggenheim Reiterates Buy on ADC Therapeutics
Benzinga Newsdesk
Thursday, April 04, 2024
ADC Therapeutics shares are trading higher. T...
Benzinga Newsdesk
ADC Therapeutics Announces Updates on LOTIS-7...
Benzinga Newsdesk
Thursday, March 28, 2024
ADC Therapeutics shares are trading higher af...
Benzinga Newsdesk
Guggenheim Initiates Coverage On ADC Therapeu...
Benzinga Newsdesk
Thursday, March 14, 2024
RBC Capital Reiterates Outperform on ADC Ther...
Benzinga Newsdesk
Wednesday, March 13, 2024
Dollar Tree Reports Weak Earnings, Joins Tesla, Arcos Dorados And Other Big Stocks Moving Lower On Wednesday
Avi Kapoor
ADC Therapeutics' 2023 Cash And Cash Equivale...
Benzinga Newsdesk
ADC Therapeutics Q4 Adjusted EPS $(0.97) May ...
Benzinga Newsdesk
Earnings Scheduled For March 13, 2024
Benzinga Insights
Tuesday, March 12, 2024
A Preview Of ADC Therapeutics's Earnings
Benzinga Insights
Wednesday, March 06, 2024
HC Wainwright & Co. Reiterates Buy on ADC The...
Benzinga Newsdesk
Tuesday, March 05, 2024
ADC Therapeutics Says Abstracts On Its Novel ...
Benzinga Newsdesk
Monday, February 26, 2024
ADC Therapeutics shares are trading higher af...
Benzinga Newsdesk
RBC Capital Maintains Outperform on ADC Thera...
Benzinga Newsdesk
Tuesday, February 20, 2024
Alaska Air To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on ADC Ther...
Benzinga Newsdesk
Thursday, January 04, 2024
ADC Therapeutics Says Regains Compliance With...
Benzinga Newsdesk
Tuesday, December 12, 2023
ADC Therapeutics Announces Initial Results fr...
Benzinga Newsdesk
Monday, November 20, 2023
Analyst Expectations for ADC Therapeutics's Future
Benzinga Insights
HC Wainwright & Co. Maintains Buy on ADC Ther...
Benzinga Newsdesk
Thursday, November 09, 2023
TD Cowen Downgrades ADC Therapeutics to Marke...
Benzinga Newsdesk
Wednesday, November 08, 2023
RBC Capital Maintains Outperform on ADC Thera...
Benzinga Newsdesk
Tuesday, November 07, 2023
ADC Therapeutics Sees Continued Decrease In T...
Benzinga Newsdesk
Show More
